<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2022-7.6.28</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-3910</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКОНОМИКА И МЕНЕДЖМЕНТ В ЗДРАВООХРАНЕНИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ECONOMICS AND HEALTHCARE MANAGEMENT</subject></subj-group></article-categories><title-group><article-title>Корпоративно-индустриальная форма организации здравоохранения</article-title><trans-title-group xml:lang="en"><trans-title>Corporate and industrial form of the organization of health care</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4134-3371</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Перхов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Perkhov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Перхов Владимир Иванович – доктор медицинских наук, доцент, главный научный сотрудник </p><p>127254, г. Москва, ул. Добролюбова, 11, Россия</p></bio><bio xml:lang="en"><p>Vladimir I. Perkhov – Dr. Sc. (Med.), Docent, Chief Research Officer</p><p>Dobrolyubova str. 11, Moscow 127254, Russian Federation </p></bio><email xlink:type="simple">finramn@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5143-7366</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Янкевич</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Yankevich</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Янкевич Дмитрий Станиславович – кандидат медицинских наук, заместитель руководителя НИИ реабилитологии </p><p>107031, г. Москва, ул. Петровка, 25, стр. 2, Россия</p></bio><bio xml:lang="en"><p>Dmitry S. Yankevich – Cand. Sc. (Med.), Deputy Head </p><p>Petrovka str. 25, building 2, Moscow 107031, Russian Federation </p></bio><email xlink:type="simple">yanson_d@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4272-0957</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петрова Марина Владимировна – доктор медицинских наук, заместитель директора по научно-клинической деятельности </p><p>107031, г. Москва, ул. Петровка, 25, стр. 2, Россия</p></bio><bio xml:lang="en"><p>Marina V. Petrova – Dr. Sc. (Med.), Deputy Director for scientific and clinical activity</p><p>Petrovka str. 25, building 2, Moscow 107031, Russian Federation </p></bio><email xlink:type="simple">mail@petrovamv.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3281-3909</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корхмазов</surname><given-names>В. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Korkhmazov</surname><given-names>V. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Корхмазов Валерий Тамазович – кандидат медицинских наук, главный врач </p><p>353915, г. Новороссийск, ул. Революции 1905 года, 30, Россия </p></bio><bio xml:lang="en"><p>Valery T. Korkhmazov – Cand. Sc. (Med.), Chief Physician</p><p>Revolyutsii 1905 goda str. 30, Novorossiysk 353915, Russian Federation </p></bio><email xlink:type="simple">korxmazov@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6023-7734</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Песенникова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pesennikova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Песенникова Елена Васильевна – кандидат медицинских наук, доцент кафедры организации и управления в сфере обращения лекарственных средств факультета управления и экономики здравоохранения </p><p>119021, г. Москва, ул. Большая Пироговская, 2, стр. 2, Россия </p></bio><bio xml:lang="en"><p>Elena V. Pesennikova – Cand. Sc. (Med.), Associate Professor at the Department of Organization and Management in the Sphere of Medicines Circulation, Faculty of Health Management and Economics</p><p>Bolshaya Pirogovskaya str. 2, building 2, Moscow 119021, Russian Federation </p></bio><email xlink:type="simple">e.v.pesennikova@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Russian Research Institute of Health<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБНУ «Федеральный научно-клинический центр реаниматологии и реабилитологии»<country>Россия</country></aff><aff xml:lang="en">Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ГБУЗ «Городская больница № 1 г. Новороссийска» Министерства здравоохранения Краснодарского края<country>Россия</country></aff><aff xml:lang="en">Municipal Hospital No. 1 of Novorossiysk of the Ministry of Health of Krasnodar Krai<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России<country>Россия</country></aff><aff xml:lang="en">I.M. Sechenov First Moscow State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>29</day><month>12</month><year>2022</year></pub-date><volume>7</volume><issue>6</issue><fpage>272</fpage><lpage>280</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Перхов В.И., Янкевич Д.С., Петрова М.В., Корхмазов В.Т., Песенникова Е.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Перхов В.И., Янкевич Д.С., Петрова М.В., Корхмазов В.Т., Песенникова Е.В.</copyright-holder><copyright-holder xml:lang="en">Perkhov V.I., Yankevich D.S., Petrova M.V., Korkhmazov V.T., Pesennikova E.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/3910">https://www.actabiomedica.ru/jour/article/view/3910</self-uri><abstract><p>В новейшей истории функции и формы здравоохранения остаются недостаточно проанализированными, несмотря на то что вложенные в медицину стимулы определяют не только объём и структуру медицинской помощи, но и основания для её оказания, которые становятся всё шире, а расходы всё больше. Пандемия COVID-19, а также возникший в 2022 г. геополитический, идеологический и экономический кризис мирового масштаба потребуют перемен, как в структуре, так и в экономике системы здравоохранения в соответствии с её основной миссией – обеспечение условий, в которых люди могли бы быть здоровыми.Целью настоящей статьи является анализ концепта современной системы здравоохранения.Материалы и методы. Использованы статистические материалы ФГБУ «ЦНИИОИЗ» Минздрава России, методы контент-анализа, аналитические материалы российских и зарубежных исследователей, в том числе размещённые в сети Интернет.Результаты. Изложенные в статье материалы позволяют говорить о появлении на протяжении жизни всего одного поколения людей новой формы организации здравоохранения, где доминируют экономические стимулы, характерные для рынка и товарного производства, вектор развития которой во многом определяют интересы международных финансовых структур, клинических корпораций, а также предприятий, производящих медицинские и фармацевтические товары. Расширение ресурсной базы в этой модели может происходить за счёт приписывания определённым заболеваниям характера эпидемии, а также за счёт превращения социальных явлений в медицинские проблемы. Поэтому всегда существует дефицит ресурсов, и устранить его без изменения парадигмы развития отрасли и квалифицированного управления не представляется возможным.Выводы. Необходимо обеспечить радикальные перемены в структуре и в экономике здравоохранения в соответствии с основной миссией отрасли – обеспечение условий, в которых люди могли бы оставаться здоровыми. Основа этих перемен – вытеснение рыночного саморегулирования и генезис смешанной общественно-частной (гибридной) экономики здравоохранения.</p></abstract><trans-abstract xml:lang="en"><p>In recent history, the functions and forms of health care remain insufficiently analyzed, despite the fact that the incentives invested in medicine determine not only the volume and structure of medical care, but also the reasons for its provision, which are becoming wider, and costs are increasing. The COVID-19 pandemic, as well as the global geopolitical, ideological and economic crisis that emerged in 2022, will require changes in both the structure and economics of the health care system in accordance with its main mission – providing conditions in which people can be healthy.The aim of this article is to analyze the concept of a modern health care system.Materials and methods. Statistical materials of the Russian Research Institute of Health, methods of content analysis, analytical materials of Russian and foreign researchers, including those posted on the Internet, were used.Results. The materials presented in the article allow us to talk about the emergence of a new form of healthcare organization during the life of just one generation of people, where economic incentives are dominant, characteristic of the market and commodity production, the vector of development of which is largely determined by the interests of international financial institutions, clinical corporations, as well as enterprises, manufacturing medical and pharmaceutical products. The expansion of the resource base in this model can occur by attributing epidemic character to certain diseases, as well as by turning social phenomena into medical problems. Therefore, there is always a shortage of resources, and it is not possible to eliminate it without changing the paradigm of the development of the industry and qualified management.Findings. Radical changes in the structure and economics of health care need to be made in line with the industry’s core mission of providing conditions in which people can stay healthy. The basis of these changes is the displacement of market self-regulation and the genesis of a mixed public-private (hybrid) healthcare economy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>организация здравоохранения</kwd><kwd>функции системы здравоохранения</kwd><kwd>расходы на медицинскую помощь</kwd><kwd>доступность медицинских услуг</kwd><kwd>пандемия COVID-19</kwd><kwd>эффективность и безопасность медицинской деятельности</kwd></kwd-group><kwd-group xml:lang="en"><kwd>organization of health care</kwd><kwd>function of a health care system</kwd><kwd>expenses on medical care</kwd><kwd>availability of medical services</kwd><kwd>COVID-19 pandemic</kwd><kwd>efficiency and safety of medical activity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">The Economist Intelligence Unit. The future of healthcare in Europe. Geneva; 2011.</mixed-citation><mixed-citation xml:lang="en">The Economist Intelligence Unit. The future of healthcare in Europe. Geneva; 2011.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz AL, Landon BE, Elshaug AG, Chernew ME, McWilliams JM. Measuring low-value care in Medicare. JAMA Intern Med. 2014; 174(7): 1067-1076. doi: 10.1001/jamainternmed.2014.1541</mixed-citation><mixed-citation xml:lang="en">Schwartz AL, Landon BE, Elshaug AG, Chernew ME, McWilliams JM. Measuring low-value care in Medicare. JAMA Intern Med. 2014; 174(7): 1067-1076. doi: 10.1001/jamainternmed.2014.1541</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Reid RO, Rabideau B, Sood N. Low-value health care services in a commercially insured population. JAMA Intern Med. 2016; 176(10): 1567-1571. doi: 10.1001/jamainternmed.2016.5031</mixed-citation><mixed-citation xml:lang="en">Reid RO, Rabideau B, Sood N. Low-value health care services in a commercially insured population. JAMA Intern Med. 2016; 176(10): 1567-1571. doi: 10.1001/jamainternmed.2016.5031</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ganguli I, Lupo C, Mainor AJ, Wang Q, Orav EJ, Rosenthal MB, et al. Assessment of prevalence and cost of care cascades after routine testing during the Medicare annual wellness visit. JAMA Netw Open. 2020; 3(12): e2029891. doi: 10.1001/jamanetworkopen.2020.29891</mixed-citation><mixed-citation xml:lang="en">Ganguli I, Lupo C, Mainor AJ, Wang Q, Orav EJ, Rosenthal MB, et al. Assessment of prevalence and cost of care cascades after routine testing during the Medicare annual wellness visit. JAMA Netw Open. 2020; 3(12): e2029891. doi: 10.1001/jamanetworkopen.2020.29891</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Carter EA, Morin PE, Lind KD. Costs and trends in utilization of low-value services among older adults with commercial insurance or Medicare Advantage. Med Care. 2017; 55(11): 931-939. doi: 10.1097/mlr.0000000000000809</mixed-citation><mixed-citation xml:lang="en">Carter EA, Morin PE, Lind KD. Costs and trends in utilization of low-value services among older adults with commercial insurance or Medicare Advantage. Med Care. 2017; 55(11): 931-939. doi: 10.1097/mlr.0000000000000809</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">PricewaterhouseCoopers’ Health Research Institute. The price of excess: Identifying waste in healthcare spending. April 2008. Health Economics Institute, Washington, DC; 1997.</mixed-citation><mixed-citation xml:lang="en">PricewaterhouseCoopers’ Health Research Institute. The price of excess: Identifying waste in healthcare spending. April 2008. Health Economics Institute, Washington, DC; 1997.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Robert Wood Johnson Foundation. What are the biggest drivers of cost in U.S. health care? Health Policy Snapshot Series. July 1, 2011.</mixed-citation><mixed-citation xml:lang="en">Robert Wood Johnson Foundation. What are the biggest drivers of cost in U.S. health care? Health Policy Snapshot Series. July 1, 2011.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральная служба государственной статистики. Национальные счета. URL: https://rosstat.gov.ru/statistics/accounts [дата доступа: 02.05.2022].</mixed-citation><mixed-citation xml:lang="en">Federal State Statistics Service. National accounts. URL: https://rosstat.gov.ru/statistics/accounts 1 [date of access: 02.05.2022]. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Перхов В.И., Колесников С.И., Песенникова Е.В. О формировании общественно-частной модели организации медицинской помощи в России. Acta biomedica scientifica. 2021; 6(3): 216-226. doi: 10.29413/ABS.2021-6.3.22</mixed-citation><mixed-citation xml:lang="en">Perhov VI, Kolesnikov SI, Pesennikova EV. Formation of publicprivate model in Russia health care organization. Acta biomedica scientifica. 2021; 6(3): 216-226. (In Russ.). doi: 10.29413/ABS.2021-6.3.22</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Петрачков И.В., Улумбекова Г.Э. Динамика объёмов потенциальных источников финансирования частных медицинских организаций с 2012 по 2019 г. ОРГЗДРАВ: Новости. Мнения. Обучение. Вестник ВШОУЗ. 2021; 7(1-23): 80-91. doi: 10.33029/2411-8621-2021-7-1-80-91</mixed-citation><mixed-citation xml:lang="en">Petrachkov IV, Ulumbekova GE. Dynamics of the volume of potential sources of financing for private medical organizations from 2012 to 2019. ORGZDRAV: Novosti. Mneniya. Obuchenie. Vestnik VShOUZ. 2021; 7(1-23): 80-91. (In Russ.). doi: 10.33029/2411-8621-2021-7-1-80-91</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Улумбекова Г.Э., Гиноян А.Б., Калашникова А.В., Альвианская Н.В. Финансирование здравоохранения в России (2021–2024 гг.). Факты и предложения. ОРГЗДРАВ: Новости. Мнения. Обучение. Вестник ВШОУЗ. 2019; 5(4-18): 4-19. doi: 10.24411/2411-8621-2019-14001</mixed-citation><mixed-citation xml:lang="en">Ulumbekova GE, Ginoyan AB, Kalashnikova AV, Al’vianskaya NV. Financing healthcare in Russia (2021–2024). Facts and suggestions. ORGZDRAV: Novosti. Mneniya. Obuchenie. Vestnik VShOUZ. 2019; 5(4-18): 4-19. (In Russ.). doi: 10.24411/2411-8621-2019-14001</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Улумбекова Г.Э., Гиноян А.Б. Финансирование здравоохранения для достижения ожидаемой продолжительности жизни в России 78 лет к 2030 году. Народонаселение. 2022; 25(1): 129-140. doi: 10.19181/population.2022.25.1.11</mixed-citation><mixed-citation xml:lang="en">Ulumbekova GE, Ginoyan AB. Financing health care to achieve a life expectancy in Russia of 78 years by 2030. Population. 2022; 25(1): 129-140. (In Russ.). doi: 10.19181/population.2022.25.1.11</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Keck CW, Reed GA. The curious case of Cuba. Am J Public Health. 2012; 102(8): e13-e22. doi: 10.2105/ajph.2012.300822</mixed-citation><mixed-citation xml:lang="en">Keck CW, Reed GA. The curious case of Cuba. Am J Public Health. 2012; 102(8): e13-e22. doi: 10.2105/ajph.2012.300822</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Eissa N. Pandemic preparedness and public health expenditure. Economies. 2020; 8(3): 60. doi: 10.3390/economies8030060</mixed-citation><mixed-citation xml:lang="en">Eissa N. Pandemic preparedness and public health expenditure. Economies. 2020; 8(3): 60. doi: 10.3390/economies8030060</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Перхов В.И., Песенникова Е.В. Особенности реакции систем здравоохранения отдельных стран на предсказанную пандемию COVID-19. Медицина и организация здравоохранения. 2020; 5(3): 4-8.</mixed-citation><mixed-citation xml:lang="en">Perhov VI, Pesennikova EV. Features of the response of health systems of individual countries to the predicted COVID-19 pandemic. Medicine and Organization of Health Care. 2020; 5(3): 4-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Null G, Dean C, Feldman M, Rasio D. Death by medicine. J Orthomol Med. 2005. 20(1): 21-34.</mixed-citation><mixed-citation xml:lang="en">Null G, Dean C, Feldman M, Rasio D. Death by medicine. J Orthomol Med. 2005. 20(1): 21-34.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Makary MA, Daniel M. Medical error – the third leading cause of death in the US. BMJ. 2016; 353: i2139. doi: 10.1136/bmj.i2139</mixed-citation><mixed-citation xml:lang="en">Makary MA, Daniel M. Medical error – the third leading cause of death in the US. BMJ. 2016; 353: i2139. doi: 10.1136/bmj.i2139</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, et al. The economic burden of preventable adverse drug reactions: A systematic review of observational studies. Expert Opin Drug Saf. 2018; 17(7): 681-695. doi: 10.1080/14740338.2018.1491547</mixed-citation><mixed-citation xml:lang="en">Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, et al. The economic burden of preventable adverse drug reactions: A systematic review of observational studies. Expert Opin Drug Saf. 2018; 17(7): 681-695. doi: 10.1080/14740338.2018.1491547</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hubbard TE, Paradis R. Real world evidence: A new era for health care innovation. Network for Excellence in Health and Innovation. 2015.</mixed-citation><mixed-citation xml:lang="en">Hubbard TE, Paradis R. Real world evidence: A new era for health care innovation. Network for Excellence in Health and Innovation. 2015.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Van-Lierop T, Bunyan C. Strengthening pharmacovigilance to reduce adverse effects of medicines. Memo/08/782. 2008: 2-5.</mixed-citation><mixed-citation xml:lang="en">Van-Lierop T, Bunyan C. Strengthening pharmacovigilance to reduce adverse effects of medicines. Memo/08/782. 2008: 2-5.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Гётше П. Смертельно опасные лекарства и организованная преступность. Как большая фарма коррумпировала здравоохранение. М.: Эксмо; 2016.</mixed-citation><mixed-citation xml:lang="en">Gyotshe P. Deadly drugs and organized crime. How big pharma corrupted healthcare. Moscow: Eksmom 2016. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Collier J. Big pharma and the UK government. Lancet. 2006; 367(9505): 97-98. doi: 10.1016/S0140-6736(06)67943-9</mixed-citation><mixed-citation xml:lang="en">Collier J. Big pharma and the UK government. Lancet. 2006; 367(9505): 97-98. doi: 10.1016/S0140-6736(06)67943-9</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ferner RE. The influence of big pharma. BMJ. 2005; 330(7496): 857-858. doi: 10.1136/bmj.330.7496.855</mixed-citation><mixed-citation xml:lang="en">Ferner RE. The influence of big pharma. BMJ. 2005; 330(7496): 857-858. doi: 10.1136/bmj.330.7496.855</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Smith R. Curbing the influence of the drug industry: A British view. PLoS Medicine. 2005; 2(9): e241. doi: 10.1371/journal.pmed.0020241</mixed-citation><mixed-citation xml:lang="en">Smith R. Curbing the influence of the drug industry: A British view. PLoS Medicine. 2005; 2(9): e241. doi: 10.1371/journal.pmed.0020241</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Miller CG, Miller DW. The real world failure of evidencebased medicine. Int J Pers Cent Med. 2011; 1(2): 295-300. doi: 10.5750/ijpcm.v1i2.70</mixed-citation><mixed-citation xml:lang="en">Miller CG, Miller DW. The real world failure of evidencebased medicine. Int J Pers Cent Med. 2011; 1(2): 295-300. doi: 10.5750/ijpcm.v1i2.70</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Every-Palmer S, Howick J. How evidence-based medicine is failing due to biased trials and selective publication. J Eval Clin Pract. 2014; 20(6): 908-914. doi: 10.1111/jep.12147</mixed-citation><mixed-citation xml:lang="en">Every-Palmer S, Howick J. How evidence-based medicine is failing due to biased trials and selective publication. J Eval Clin Pract. 2014; 20(6): 908-914. doi: 10.1111/jep.12147</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Iriart C. Capital financiero versus complejo medico-industrial: Los desafíos de las agencias Regulatorias [Financial capital versus medical-industrial complex: challenges for the regulatory agencies]. Cien Saude Colet. 2008; 13(5): 1619-1626. [In Spanish]. doi: 10.1590/s1413-81232008000500025</mixed-citation><mixed-citation xml:lang="en">Iriart C. Capital financiero versus complejo medico-industrial: Los desafíos de las agencias Regulatorias [Financial capital versus medical-industrial complex: challenges for the regulatory agencies]. Cien Saude Colet. 2008; 13(5): 1619-1626. [In Spanish]. doi: 10.1590/s1413-81232008000500025</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Stocker K, Waitzkin H, Iriart C. The exportation of managed care to Latin America. New Engl J Med. 1999; 340(14): 1131-1136. doi: 10.1056/nejm199904083401425</mixed-citation><mixed-citation xml:lang="en">Stocker K, Waitzkin H, Iriart C. The exportation of managed care to Latin America. New Engl J Med. 1999; 340(14): 1131-1136. doi: 10.1056/nejm199904083401425</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Iriart C. The transnationalization of the health care system in Argentina. In: Mackintosh M, Koivusalo M. (eds) Commercialization of Health Care. Social Policy in a Development Context. London: Palgrave Macmillan; 2005: 51-65. doi: 10.1057/9780230523616_4</mixed-citation><mixed-citation xml:lang="en">Iriart C. The transnationalization of the health care system in Argentina. In: Mackintosh M, Koivusalo M. (eds) Commercialization of Health Care. Social Policy in a Development Context. London: Palgrave Macmillan; 2005: 51-65. doi: 10.1057/9780230523616_4</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Bello W, Cunningham S. The World Bank &amp; The IMF. Z Magazine. 1994; 7(7): 8.</mixed-citation><mixed-citation xml:lang="en">Bello W, Cunningham S. The World Bank &amp; The IMF. Z Magazine. 1994; 7(7): 8.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Шишкин С.В. Реформа финансирования российского здравоохранения. М., 2000.</mixed-citation><mixed-citation xml:lang="en">Shishkin SV. Russian healthcare financing reform. Moscow, 2000. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Гайдаров Г.М., Алексеева Н.Ю., Макаров С.В., Абашин Н.Н. Организация обязательного медицинского страхования в современных условиях: Учебное пособие для студентов. Иркутск: ИГМУ, 2016.</mixed-citation><mixed-citation xml:lang="en">Gajdarov GM, Alekseeva NYu, Makarov SV, Abashin NN. Organization of compulsory health insurance in modern conditions: Study guide for students. Irkutsk: IGMU, 2016. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Simborg DW. DRG creep: A new hospital-acquired disease. New Eng J Med. 1981; 304(26): 1602-1604. doi: 10.1056/NEJM198106253042611</mixed-citation><mixed-citation xml:lang="en">Simborg DW. DRG creep: A new hospital-acquired disease. New Eng J Med. 1981; 304(26): 1602-1604. doi: 10.1056/NEJM198106253042611</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Lee K, Wi SB, Choi BY. The analysis of medical care behaviors influencing New Diagnosis-Related Groups (DRG) based payment-focused on hospitalized patients with medical illness. Korea Journal of Hospital Management. 2020; 25(2): 45-56.</mixed-citation><mixed-citation xml:lang="en">Lee K, Wi SB, Choi BY. The analysis of medical care behaviors influencing New Diagnosis-Related Groups (DRG) based payment-focused on hospitalized patients with medical illness. Korea Journal of Hospital Management. 2020; 25(2): 45-56.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Orient JM. An ode to DRG creep. Ann Intern Med. 1985; 102(4): 565-565. doi: 10.7326/0003-4819-102-4-565_2</mixed-citation><mixed-citation xml:lang="en">Orient JM. An ode to DRG creep. Ann Intern Med. 1985; 102(4): 565-565. doi: 10.7326/0003-4819-102-4-565_2</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Seiber EE. Physician code creep: Evidence in Medicaid and State Employee Health Insurance billing. Health Care Financ Rev. 2007; 28(4): 83.</mixed-citation><mixed-citation xml:lang="en">Seiber EE. Physician code creep: Evidence in Medicaid and State Employee Health Insurance billing. Health Care Financ Rev. 2007; 28(4): 83.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">НИИОЗММ Департамента здравоохранения Москвы. Онлайн-семинар с представителями Всемирного банка «Минимизация и управление последующими волнами COVID-19 в процессе возобновления экономической деятельности: последние данные и уроки из европейских стран». URL: https://mosgorzdrav.ru/ru-RU/event/default/card/2754.html [дата доступа: 01.05.2022].</mixed-citation><mixed-citation xml:lang="en">Online Seminar with World Bank Representatives on “Minimizing and Managing Subsequent Waves of COVID-19 During Economic Reopening: Latest Data and Lessons from European Countries”. URL: https://mosgorzdrav.ru/ru-RU/event/default/card/2754.html [date of access: 01.05.2022]. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Банк России. Доклад для общественных консультаций. Предложения по развитию медицинского страхования в Российской Федерации. 2017. URL: https://cbr.ru/Content/Document/File/50686/Consultation_Paper_171003_03.pdf [дата доступа: 18.04.2022].</mixed-citation><mixed-citation xml:lang="en">Bank of Russia. Report for public consultation. Proposals for the development of health insurance in the Russian Federation. 2017. URL: https://cbr.ru/Content/Document/File/50686/Consultation_Paper_171003_03.pdf [date of access: 18.04.2022]. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Smith PC. Некоторые размышления о приоритетных направлениях работы по укреплению систем здравоохранения в Европейском регионе ВОЗ. Всемирная организация здравоохранения. Европейское региональное бюро. 2015. URL: https://apps.who.int/iris/handle/10665/341677 [дата доступа: 18.04.2022]</mixed-citation><mixed-citation xml:lang="en">Smith PC. Some thoughts on priorities for health systems strengthening in the WHO European Region. World Health Organization. European Regional Office. 2015. URL: https://apps.who.int/iris/handle/10665/341677 [date of access: 18.04.2022]. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Курмангулов А.А., Решетникова Ю.С., Фролова О.И., Брынза Н.С. и др. Особенности внедрения метода 5S бережливого производства в систему здравоохранения Российской Федерации. Кубанский научный медицинский вестник. 2019: 26(2): 140-149. doi: 10.25207/1608-6228-2019-26-2-140-149</mixed-citation><mixed-citation xml:lang="en">Kurmangulov AA, Reshetnikova YuS, Frolova OI, Brynza NS, et al. Features of the implementation of the 5S method of lean manufacturing in the healthcare system of the Russian Federation. Kubanskii Nauchnyi Meditsinskii Vestnik. 2019; 26(2): 140-149. (In Russ.). doi: 10.25207/1608-6228-2019-26-2-140-149</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Gunz HP, Lichtenstein BMB, Long RG. Self-organization in career systems: A view from complexity science. Management. 2002; 5(1): 63-88. doi: 10.3917/mana.051.0063</mixed-citation><mixed-citation xml:lang="en">Gunz HP, Lichtenstein BMB, Long RG. Self-organization in career systems: A view from complexity science. Management. 2002; 5(1): 63-88. doi: 10.3917/mana.051.0063</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
